Occlusive Retinal Vasculitis Following Intravitreal Drug Delivery

References

• Personal communication. David harmon, president, market scope, LLC. https://www.market-scope.com/
   Google Scholar
• Personal communication. Dr. George Williams. Courtesy of the American Academy of Ophthalmology, IRIS Registry. https://www.aao.org/iris-registry
   Google Scholar
• Grzybowski A, Told R, Sacu S, et al. 2018 update on intravitreal injections: euretina expert consensus recommendations. Ophthalmologica. 2018;239(4):181–193. doi:10.1159/000486145.
   PubMed Web of Science ®Google Scholar
• Avery RL, Bakri SJ, Blumenkranz MS, et al. Intravitreal injection technique and monitoring: updated guidelines of an expert panel. Retina. 2014 Dec;34(Suppl 12):S1–S18. doi:10.1097/IAE.0000000000000399.
   PubMedGoogle Scholar
• Ramos MS, Xu LT, Singuri S, et al. Patient-reported complications after intravitreal injection and their predictive factors. Ophthalmol Retina. 2020 Oct 12:S2468-6530(20)30407–3. Online ahead of print. doi:10.1016/j.oret.2020.09.024.
   PubMedGoogle Scholar
• Storey PP, Patel D, Garg S. Endophthalmitis following intravitreal injection of anti-vascular endothelial growth factor agents. Can J Ophthalmol. 2020 Aug;55(4):286–292. doi:10.1016/j.jcjo.2020.01.015. Epub 2020 Mar 20.
   PubMed Web of Science ®Google Scholar
• Sampat KM, Garg SJ. Complications of intravitreal injections. Curr Opin Ophthalmol. 2010;21(3):178–183. doi:10.1097/ICU.0b013e328338679a.
   PubMed Web of Science ®Google Scholar
• Jager RD, Aiello LP, Patel SC, Cunningham ET Jr. Risks of intravitreous injection: a comprehensive review. Retina. 2004 Oct;24(5):676–698. doi:10.1097/00006982-200410000-00002.
   PubMed Web of Science ®Google Scholar
• Csaky KG. Ocular inflammation after intravitreal injections. A review of data on incidence and implications. Retinal Physician. January 1, 2018. https://www.retinalphysician.com/issues/2018/january-2018/ocular-inflammation-after-intravitreal-injections
   Google Scholar
• Takakura A, Tessler HH, Goldstein DA, et al. Viral retinitis following intraocular or periocular corticosteroid administration: a case series and comprehensive review of the literature. Ocul Immunol Inflamm. 2014;22(3):175–182. doi:10.3109/09273948.2013.866256.
   PubMed Web of Science ®Google Scholar
• Penha FM, Rodrigues EB, Maia M, et al. Retinal and ocular toxicity in ocular application of drugs and chemicals–part I: animal models and toxicity assays. Ophthalmic Res. 2010;44(2):82–104. doi:10.1159/000312817.
   PubMed Web of Science ®Google Scholar
• Penha FM, Rodrigues EB, Maia M, et al. Retinal and ocular toxicity in ocular application of drugs and chemicals–part II: retinal toxicity of current and new drugs. Ophthalmic Res. 2010;44(4):205–224. doi:10.1159/000316695.
   PubMed Web of Science ®Google Scholar
• Hancock HA, Guidry C, Read RW, Ready EL, Kraft TW. Acute aminoglycoside retinal toxicity in vivo and in vitro. Invest Ophthalmol Vis Sci. 2005;46(12):4804–4808. doi:10.1167/iovs.05-0604.
   PubMed Web of Science ®Google Scholar
• Thomas T, Galiani D, Brod RD. Gentamicin and other antibiotic toxicitiy. Ophthalmol Clin North Am. 2001;14(4):611–624. doi:10.1016/S0896-1549(05)70261-3.
   PubMedGoogle Scholar
• Campochiaro PA, Lim JI. Aminoglycoside toxicity in the treatment of endophthalmitis. The aminoglycoside toxicity study group. Arch Ophthalmol. 1994 Jan;112(1):48–53. doi:10.1001/archopht.1994.01090130058017.
   PubMedGoogle Scholar
• Campochiaro PA, Conway BP. Aminoglycoside toxicity–a survey of retinal specialists. Implications for ocular use. Arch Ophthalmol. 1991;109(7):946–950. doi:10.1001/archopht.1991.01080070058035.
   PubMed Web of Science ®Google Scholar
• Querques L, Miserocchi E, Modorati G, Querques G, Bandello F. Hemorrhagic occlusive retinal vasculitis after inadvertent intraocular perforation with gentamycin injection. Eur J Ophthalmol. 2017;27(2):e50–e53. doi:10.5301/ejo.5000874.
   PubMed Web of Science ®Google Scholar
• Ledesma-Gil G, Spaide RF. Optical coherence tomography angiography and fluorescein angiography findings in aminoglycoside toxicity. Retina. 2020;40(6):e26–e27. doi:10.1097/IAE.0000000000002822.
   PubMed Web of Science ®Google Scholar
• Witkin AJ, Chang DF, Jumper JM, et al. Vancomycin-associated hemorrhagic occlusive retinal vasculitis: clinical characteristics of 36 eyes. Ophthalmology. 2017;124(5):583–595. doi:10.1016/j.ophtha.2016.11.042.
   PubMed Web of Science ®Google Scholar
• Witkin AJ, Shah AR, Engstrom RE, et al. Postoperative hemorrhagic occlusive retinal vasculitis: expanding the clinical spectrum and possible association with vancomycin. Ophthalmology. 2015;122(7):1438–1451. doi:10.1016/j.ophtha.2015.03.016.
   PubMed Web of Science ®Google Scholar
• Schwartz SG, Relhan N, O’Brien TP, Flynn HW Jr. A new complication associated with the use of prophylactic intracameral antibiotics: hemorrhagic occlusive retinal vasculitis. Ophthalmology. 2017;124(5):578–579. doi:10.1016/j.ophtha.2017.01.038.
   PubMed Web of Science ®Google Scholar
• Nicholson LB, Kim BT, Jardón J, et al. Severe bilateral ischemic retinal vasculitis following cataract surgery. Ophthalmic Surg Lasers Imaging Retina. 2014;45(4):338–342. doi:10.3928/23258160-20140605-01.
   PubMed Web of Science ®Google Scholar
• Miyake H, Miyazaki D, Shimizu Y, et al. Toxicities of and inflammatory responses to moxifloxacin, cefuroxime, and vancomycin on retinal vascular cells. Sci Rep. 2019 Jul 5;9(1):9745. doi:10.1038/s41598-019-46236-2.
   PubMedGoogle Scholar
• Witkin AJ, Hahn P, Murray TG, et al. Occlusive retinal vasculitis following intravitreal brolucizumab. J Vitreoretin Dis. 2020;4(4):269–279. doi:10.1177/2474126420930863.
   PubMedGoogle Scholar
• Baumal CR, Spaide RF, Vajzovic L, et al. Retinal vasculitis and intraocular inflammation after intravitreal injection of brolucizumab. Ophthalmology. 2020;127(10):1345–1359. doi:10.1016/j.ophtha.2020.04.017.
   PubMed Web of Science ®Google Scholar
• Monés J, Srivastava SK, Jaffe GJ, et al. Risk of inflammation, retinal vasculitis, and retinal occlusion-related events with brolucizumab: post hoc review of HAWK and HARRIER. Ophthalmology. 2020 Nov 15:S0161-6420(20)31075–7. Online ahead of print. doi:10.1016/j.ophtha.2020.11.011.
   Web of Science ®Google Scholar
• Do D Absence of safety signal for occlusive retinal vasculitis with intravitreal aflibercept injection. Presented at the Retina Society 2020 VR meeting; September 21e22, 2020. https://avenue.live/retina-society/presentations/do-diana-absence-of-safety-signal.pdf. Accessed January 18, 2021.
   Google Scholar
• Iyer PG, Peden MC, Suñer IJ, Patel N, Dubovy SR, Albini TA. Brolucizumab-related retinal vasculitis with exacerbation following ranibizumab retreatment: A clinicopathologic case study. Am J Ophthalmol Case Rep. 2020 Nov 10;20:100989. doi:10.1016/j.ajoc.2020.100989.
   PubMedGoogle Scholar
• Mirshahi A, Lashay A, Mehrabi Bahar MR, Abrishami M. Consequences of inadvertent intravitreal Mitomycin C injection. Int J Retina Vitreous. 2018 Feb 12;4:7. doi:10.1186/s40942-018-0110-6.
   PubMedGoogle Scholar
• Ryoo NK, Kim MK, Wee WR. Consequences of accidental mitomycin C intraocular injection. JAMA Ophthalmol. 2013;131(9):1197. doi:10.1001/jamaophthalmol.2013.347.
   PubMedGoogle Scholar
• Nuyts RM, Van Diemen HA, Greve EL. Occlusion of the retinal vasculature after trabeculectomy with mitomycin C. Int Ophthalmol. 1994;18(3):167–170. doi:10.1007/BF00915967.
   PubMed Web of Science ®Google Scholar
• Çiftçi S, Çiftçi L, Dağ U. Hemorrhagic retinal infarction due to inadvertent overdose of cefuroxime in cases of complicated cataract surgery: retrospective case series. Am J Ophthalmol. 2014;157(2):421–425. doi:10.1016/j.ajo.2013.10.018.
   PubMed Web of Science ®Google Scholar
• Conrady CD, Shakoor A. Rituximab-associated retinal occlusive vasculopathy: A case report and literature review. Ocul Immunol Inflamm. 2020;28(4):622–625. doi:10.1080/09273948.2019.1611874.
   PubMed Web of Science ®Google Scholar
• Chen KJ, Chen YP, Wang NK, et al. Retinal vasculitis and posterior pole preretinal exudates in exogenous bacterial endophthalmitis: management and visual outcomes. Ocul Immunol Inflamm. 2020 Oct 6:1–6. Online ahead of print. doi:10.1080/09273948.2020.1814343.
   Web of Science ®Google Scholar
• Sodhi GS, Franklin QJ, Wagner AL, Kapoor KG. Successful clinical outcome of vancomycin-induced hemorrhagic occlusive retinal vasculitis. Ocul Immunol Inflamm. 2019 Aug 16:1–4. Online ahead of print. doi:10.1080/09273948.2019.1640881.
   PubMed Web of Science ®Google Scholar
• Greenberg E, Dedeker C, Olson HJ, Montezuma RS. Postoperative cataract endophthalmitis masquerading as hemorrhagic occlusive retinal vasculitis (HORV): A case report. Ocul Immunol Inflamm. 2019 Aug 15:1–4. Online ahead of print. doi:10.1080/09273948.2019.1634216.
   PubMed Web of Science ®Google Scholar
• Tabuenca Del Barrio L, Mozo Cuadrado M, Compains Silva E, Aliseda Pérez De Madrid D, Heras Mulero H. Haemophilus influenzae endogenous endophthalmitis in an immunocompetent host. Ocul Immunol Inflamm. 2020 Jul 9:1–3. Online ahead of print. doi:10.1080/09273948.2020.1767794.
   PubMed Web of Science ®Google Scholar
• Arepalli S, Modi YS, Deasy R, Srivastava SK. Mild bilateral hemorrhagic occlusive retinal vasculitis following intracameral vancomycin administration in cataract surgery. Ophthalmic Surg Lasers Imaging Retina. 2018;49(5):369–373. doi:10.3928/23258160-20180501-12.
   PubMed Web of Science ®Google Scholar
• Todorich B, Faia LJ, Thanos A, et al. Vancomycin-associated hemorrhagic occlusive retinal vasculitis: A clinical-pathophysiological analysis. Am J Ophthalmol. 2018;188:131–140. doi:10.1016/j.ajo.2018.01.030.
   PubMed Web of Science ®Google Scholar
• Subbiah S, McAvoy CE, Best JL. Retinal vasculitis as an early sign of bacterial post-operative endophthalmitis. Eye (Lond). 2010;24(8):1410–1411. doi:10.1038/eye.2010.18.
   PubMed Web of Science ®Google Scholar
• Jeng BH, Kaiser PK, Lowder CY. Retinal vasculitis and posterior pole “hypopyons” as early signs of acute bacterial endophthalmitis. Am J Ophthalmol. 2001;131(6):800–802. doi:10.1016/S0002-9394(00)00929-6.
   PubMed Web of Science ®Google Scholar
• Conrady CD, Feistmann JA, Roller AB, Boldt HC, Shakoor A. Hemorrhagic vasculitis and retinopathy heralding as an early sign of bacterial endophthalmitis after intravitreal injection. Retin Cases Brief Rep. 2019;13(4):329–332. doi:10.1097/ICB.0000000000000601.
   PubMedGoogle Scholar
• Weinstein JE, Greven MA. Endophthalmitis presenting as retinal vasculitis less than 24 hours after aflibercept injection: a case report. Retin Cases Brief Rep. 2020 Oct 5;Publish Ahead of Print. doi:10.1097/ICB.0000000000001069. Online ahead of print.
   Google Scholar
• Cunningham ET Jr, Zierhut M. Retinal vasculitis. Ocul Immunol Inflamm. 2020;28(8):1159–1162. doi:10.1080/09273948.2020.1837550.
   PubMed Web of Science ®Google Scholar